Zevra Therapeutics, Inc. (ZVRA)
12.16
+0.10
(+0.83%)
USD |
NASDAQ |
Sep 11, 14:42
Zevra Therapeutics Gross Profit (TTM) : 128.53M for June 30, 2026
Gross Profit (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 128.53M |
| March 31, 2026 | 102.59M |
| December 31, 2025 | 86.08M |
| September 30, 2025 | 61.25M |
| June 30, 2025 | 34.97M |
| March 31, 2025 | 20.85M |
| December 31, 2024 | 3.571M |
| September 30, 2024 | 6.589M |
| June 30, 2024 | 11.05M |
| March 31, 2024 | 21.00M |
| December 31, 2023 | 23.81M |
| September 30, 2023 | 15.08M |
| June 30, 2023 | 14.72M |
| March 31, 2023 | 8.075M |
| December 31, 2022 | 8.995M |
| September 30, 2022 | 9.754M |
| June 30, 2022 | 7.419M |
| March 31, 2022 | 17.27M |
| December 31, 2021 | 24.43M |
| September 30, 2021 | 21.98M |
| June 30, 2021 | 21.98M |
| March 31, 2021 | 17.32M |
| December 31, 2020 | 7.62M |
| September 30, 2020 | 6.976M |
| Date | Value |
|---|---|
| June 30, 2020 | 17.36M |
| March 31, 2020 | 11.02M |
| December 31, 2019 | 9.59M |
| September 30, 2019 | 10.16M |
| June 30, 2019 | -0.311M |
| March 31, 2019 | -0.319M |
| December 31, 2018 | -0.324M |
| September 30, 2018 | -0.33M |
| June 30, 2018 | -0.338M |
| March 31, 2018 | -0.339M |
| December 31, 2017 | -0.336M |
| September 30, 2017 | -0.329M |
| June 30, 2017 | -0.284M |
| March 31, 2017 | -0.229M |
| December 31, 2016 | -0.175M |
| September 30, 2016 | -0.12M |
| June 30, 2016 | -0.099M |
| March 31, 2016 | -0.09M |
| December 31, 2015 | -0.084M |
| September 30, 2015 | -0.0799M |
| June 30, 2015 | -0.0589M |
| March 31, 2015 | -0.0389M |
| December 31, 2014 | -0.0189M |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (TTM) Benchmarks
| Innoviva, Inc. | 317.57M |
| Collegium Pharmaceutical, Inc. | 485.09M |
| Johnson & Johnson | 66.63B |
| Ligand Pharmaceuticals, Inc. | 244.88M |
| Harrow, Inc. | 201.96M |